AbbVie holds off another Humira challenger with Alvotech deal
Bio Pharma Dive
MARCH 9, 2022
A settlement will allow the Iceland-based drugmaker to launch its Humira copycat, currently under FDA review, in the U.S. beginning next July.
Sat.Mar 05, 2022 - Fri.Mar 11, 2022
331 
The biggest challenge for healthcare
World of DTC Marketing
MARCH 5, 2022
American healthcare is the most expensive globally, but it’s not close to being the best. Our healthcare system has become like a mass-market retailer, in the door to treat the problem and out the door with an Rx or other treatment recommendation. What’s missing is the basic premise of any good care: the focus on the person, not just the condition.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Boehringer backs AI-powered anti-infective startup ArrePath
pharmaphorum
MARCH 7, 2022
A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including the Boehringer Ingelheim Venture Fund. The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging based drug discovery platform, used to identify compounds with new and under-exploited mechanisms of action.
Top Reasons to See a Chiropractor in Solana Beach CA
Pharma Mirror
MARCH 11, 2022
As we get older, it becomes more challenging to take care of our bodies. Injuries, aches, and pains are more likely to occur. To combat aging, it’s smart to invest in your physical health. One of the primary ways that people stay healthy in California is by receiving chiropractic care. A chiropractor in Solana Beach CA can help you maintain your health while avoiding future injuries.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Sanofi, with positive data in hand, to ask for approval of longer-lasting hemophilia therapy
Bio Pharma Dive
MARCH 9, 2022
Patients with severe hemophilia A who were given the drug had, on average, less than one bleeding event over a year, results that Sanofi and partner Sobi believe will pass muster with regulators.
We need evidence-based digital health
World of DTC Marketing
MARCH 6, 2022
Digital health companies aim to address the numerous health care challenges, including poor patient engagement, communication gaps between patients and providers, lack of longitudinal data, inconvenience of care delivery, and insufficient clinical decision support for providers and patients. Maybe, however, they should check with patients first. A 2016 study reported that 259,000 digital health apps were available for consumers.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Japan tops CPhI ‘API Quality’ ranking for second year
Pharma Mirror
MARCH 11, 2022
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers Tokyo: CPhI Japan 2022 returns as a SMART event – with live exhibition at the Big Sight Exhibition Center in Tokyo (20-22 April) alongside an online networking platform – as CPhI data[1] confirms the country continues to top global ‘API quality’ rankings, with Japanese respondents bullish on growth in 2022 forecasting a CAGR of 14% on average.
After slower-than-expected review, Pfizer and Arena to close buyout deal
Bio Pharma Dive
MARCH 10, 2022
Arena Pharmaceuticals expects its $7 billion sale to Pfizer to close Friday, ending a slightly protracted regulatory review that raised questions about whether the deal would be cleared as anticipated.
Edelman Trust Barometer raises questions
World of DTC Marketing
MARCH 11, 2022
After two years of pandemic fatigue, healthcare trust is at an all-time low, according to Edelman’s Trust Barometer Special Report on Trust in Healthcare. Still, the report may be too generalized for every healthcare player. Trust is a vital determinant of health behaviors and outcomes, but COVID-19 has dramatically influenced how the public makes healthcare decisions, according to the February online survey of more than 10,000 people in 10 countries worldwide.
Waiting times for cancer referrals highest on record
Pharma Times
MARCH 11, 2022
93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks but this has fallen to just 75%
Emmes Acquires Casimir, Its Fourth Major Acquisition
Pharma Mirror
MARCH 11, 2022
Casimir Further Differentiates Emmes’ Industry-Leading Rare Disease Research Capabilities Rockville, MD, March 10, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has worked with regulators, sponsors and patients to develop outcome measures that capture the nuan
AbbVie keeps up dealmaking pace in neuroscience
Bio Pharma Dive
MARCH 11, 2022
On the heels of its Syndesi acquisition, the company has announced an agreement with Gedeon Richter focused on researching and developing new dopamine-regulating drugs for neuropsychiatric diseases.
AbbVie sucks
World of DTC Marketing
MARCH 10, 2022
AbbVie’s wall of patents protecting its top-selling drug Humira will keep another would-be competitor from entering the U.S. market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. Sales of Humira earned AbbVie $20.7 billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money.
UK COVID-19 cases rising among those aged 55 and older
Pharma Times
MARCH 10, 2022
Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Common Risks of Working as a Healthcare Professional
Pharma Mirror
MARCH 11, 2022
The healthcare professions are rewarding, stimulating, prestigious, and lucrative. Few other professionals can say that their daily task is to save lives. The post Common Risks of Working as a Healthcare Professional appeared first on Pharma Mirror Magazine.
Gilead says breast cancer drug succeeded in key study, but offers few details
Bio Pharma Dive
MARCH 7, 2022
The study is an important test of whether the drug, called Trodelvy, can live up to expectations set by Gilead's $21 billion deal to acquire it.
Is pharma being unfairly targeted by the media?
World of DTC Marketing
MARCH 8, 2022
It’s hard not to read a story about how high drug prices are hurting patients, but while drug prices are too high and outpacing inflation, insurers, PBMs, and hospitals are taking huge slices of healthcare dollars with little notice from Congress and the media. According to KFF “half of all Part D covered drugs (50% of 3,343 drugs) and nearly half of all Part B covered drugs (48% of 568 drugs) had price increases more significant than inflation between July 2019 and July 2020, which
First treatment for adults across full spectrum of chronic heart failure
Pharma Times
MARCH 7, 2022
Largest unmet need in cardiovascular medicine finally receives approved therapy
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
8 Effective Ways To Enhance Your Health In 2022
Pharma Mirror
MARCH 7, 2022
With the recent pandemic lingering on, and the new devastating news of a potential global war, prioritizing your overall health and well-being has never been more critical. While the covid19 pandemic showed us just how important physical health and a robust immune system are, the news of the war is quickly showing us the importance of mental well-being.
Novartis turns to Voyager for nervous system gene therapies
Bio Pharma Dive
MARCH 8, 2022
The deal, which carries a $54 million upfront payment, could give Novartis access to as many as five of Voyager's capsids, which would be used to develop gene therapies for the central nervous system.
Small biotech start-ups should look to web analytics
World of DTC Marketing
MARCH 7, 2022
Biotech start-ups face challenges in raising money and cutting through the “noise” of other prominent pharma marketers, but their website can provide a wealth of insights into what visitors want to know. One of our most frequent requests is to analyze small biotech websites. Some are in the start-up mode and don’t have the money to hire full-time digital marketers; others may have just received limited approval of one of their drugs and are still in clinical trials.
Roche launches molecular system to increase diagnostic testing access
Pharma Times
MARCH 7, 2022
Fully-automated molecular system with small footprint provides greater flexibility for laboratories without much space
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Ex-NHS Digital head says merger into NHS England is a mistake
pharmaphorum
MARCH 7, 2022
The former chair of NHS Digital has slammed the decision to absorb the unit into NHS England as a “significant retrograde step” that could undermine citizens’ rights over their health data. In a letter to the BMJ, Kingsley Manning – who headed NHS Digital between 2013 and 2016 – said that the move is a “grave error” that could threaten the confidentiality and use of patient data.
Moderna extends patent waiver for COVID vaccine, but only for lower-income countries
Bio Pharma Dive
MARCH 8, 2022
Health advocates say Moderna is narrowing its pledge not to enforce patents worldwide for the duration of the pandemic, while the company argues that, in higher-income countries, vaccine supply isn't a barrier to access anymore.
Looking at Women’s Leadership in Life Science Industries on International Women’s Day
XTalks
MARCH 8, 2022
On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation. From leading COVID-19 vaccine developments to being at the helm of the latest gene therapies and inventing ground-breaking DNA technologies like CRISPR, women have been at the forefront of some of the most leading-edge scientific discov
The NHS: Prevention, Personalisation and Performance
Pharma Times
MARCH 10, 2022
The government’s planned ‘Road to Recovery’ will have a new focus on prevention
Alliance aims to drive inclusivity in trials backed by digital devices
pharmaphorum
MARCH 11, 2022
A consortium led by the Digital Medicine Society (DiMe) has been set up to try to end inequities in access to clinical trials, focusing on the increasing number of studies that use digital devices to allow participation. The organisation has teamed up with drugmakers GlaxoSmithKline and Amgen as well as partners in the clinical research, patient engagement and data analytics sector on a project to develop the principles that can be used to make sure trials are designed from the ground up to allo
Bluebird's CFO resigns as cash woes raise doubts about its future
Bio Pharma Dive
MARCH 7, 2022
The gene therapy developer's top financial executive, Gina Consylman, is stepping down amid concerns the company needs to raise additional cash to survive for more than a year.
Drugs facing the most patent expirations this year
Drug Patent Watch
MARCH 10, 2022
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…. The post Drugs facing the most patent expirations this year appeared first on DrugPatentWatch - Make Better Decisions.
Abivax reports promising rheumatoid arthritis results
Pharma Times
MARCH 11, 2022
Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content